Jim Simons’s Medline Inc MDLN Stock Holding History

Jim Simons’s Portfolio MDLN Stock Details MDLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-143,700	Closed	-$6.39M	–	3757
2026 Q1	$6.39M	Buy	+143,700	New	+$6.34M	0.01%	1220

Other funds holding MDLN

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return

H&F Corporate Investors X San Francisco, California $2.8B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Jim Simons's MDLN Position: Q2 2026 in Review

Jim Simons sold out of Medline Inc (MDLN) in Q2 2026, closing a stake of 143,700 shares — an estimated $6.39M sold.

Jim Simons first reported a position in MDLN in Q1 2026 and held it in 1 quarter. The position peaked at $6.39M in Q1 2026. 410 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

Jim Simons reported no remaining Medline Inc position as of Q2 2026 after selling out during the quarter.
Jim Simons sold 143,700 Medline Inc shares in Q2 2026, an estimated $6.39M.
Jim Simons first reported a position in Medline Inc in Q1 2026 and held it in 1 quarter.
Jim Simons's Medline Inc position peaked at $6.39M in Q1 2026.
410 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.